Top compounds associated with response to LGALS9C


Feature Type Standardized
Nominal ANOVA
mRNA dexamethasone CTRPv2 pan-cancer AAC 0.044 0.2
mRNA NVP-BEZ235 CTRPv2 pan-cancer AAC -0.054 0.2
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.2
mRNA nelarabine CTRPv2 pan-cancer AAC 0.05 0.2
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.043 0.2
mRNA BRD-K34485477 CTRPv2 pan-cancer AAC -0.1 0.2
mRNA ELCPK CTRPv2 pan-cancer AAC 0.065 0.2
mRNA BRD-K92856060 CTRPv2 pan-cancer AAC -0.045 0.2
mRNA CIL56 CTRPv2 pan-cancer AAC -0.06 0.2
mRNA BRD6340 CTRPv2 pan-cancer AAC -0.043 0.2
Download CSV